Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Leuk Lymphoma. 2019 Oct 16;61(2):309–317. doi: 10.1080/10428194.2019.1672052

Table 1.

Patient demographics and baseline characteristics

Characteristics Population
(N = 34)
Median age, y (range) 59 (26-82)
Sex, male, n (%) 24 (71)
ECOG performance status, n (%)
 0 7 (21)
 1 24 (71)
 2 3 (9)
Median number of prior therapies, n (range) 4 (1-10)
Prior stem cell transplantation, n (%) 14 (41)
Disease type/subtype, n (%)
 Diffuse large B-cell lymphoma (DLBCL) 12 (41)
 Classical Hodgkin lymphoma (HL) 8 (24)
 Follicular lymphoma (FL) 5 (12)
 Mantle cell lymphoma (MCL) 3 (6)
 Chronic lymphocytic leukemia (CLL/SLL) 2 (6)
 Anaplastic large cell lymphoma (ALCL) 1 (3)
 Marginal zone lymphoma (MZL) 1(3)
 Natural killer (NK)/T-cell lymphoma (TCL) 1 (3)
 Peripheral T-cell lymphoma (PTCL) 1 (3)